• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

    33.95 -1.51 (-4.26%)
    Streaming Delayed Price Updated: 2:07 PM EST, Jan 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 10,278,710
    Open 35.16
    Bid (Size) 33.94 (400)
    Ask (Size) 33.96 (200)
    Prev. Close 35.46
    Today's Range 33.60 - 35.16
    52wk Range 23.97 - 72.98
    Shares Outstanding 191,922,517
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗
    The development comes as attention remains on Hims’ longer-term business expansion initiatives. 
    Via Stocktwits
    News headline image
    1 High-Flying Stock on Our Watchlist and 2 We Question
    "You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
    Via StockStory

    Performance

    YTD
    +1.6%
    +1.6%
    1 Month
    -13.2%
    -13.2%
    3 Month
    -41.6%
    -41.6%
    6 Month
    -33.7%
    -33.7%
    1 Year
    +22.7%
    +22.7%

    More News

    Read More
    News headline image
    The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026
    Via MarketMinute
    Topics Economy Intellectual Property
    News headline image
    2 Russell 2000 Stocks Worth Investigating and 1 We Avoid
    Via StockStory
    News headline image
    Nasdaq Bears Dig In: Short Interest Hits Record 18.38 Billion Shares Amid Valuation Anxiety
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    Hims & Hers Hit A GLP-1 Speed Bump This Year — But Growth Is Just Cooling, Not Cracking ↗
    Via Stocktwits
    News headline image
    3 Profitable Stocks for Long-Term Investors
    Via StockStory
    News headline image
    2 Top Stocks to Buy With $500 Right Now ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy Stocks
    News headline image
    3 Stocks High on My Watch List to Buy ↗
    Via The Motley Fool
    News headline image
    1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm
    Via StockStory
    News headline image
    1 Stock Under $50 with Exciting Potential and 2 We Brush Off
    Via StockStory
    News headline image
    Hims & Hers Brings Comprehensive Weight Loss Programme to the UK
    From Hims & Hers
    Via Business Wire
    News headline image
    5 High Short-Interest Stocks to Buy Before Q1 2026 ↗
    Via MarketBeat
    News headline image
    From Hype to P&L: Hospitals Now Buying AI That Pays
    From USA News Group
    Via GlobeNewswire
    News headline image
    2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm
    Via StockStory
    News headline image
    Hims & Hers Continues Major International Expansion With Official Entry Into Canada
    From Hims & Hers
    Via Business Wire
    News headline image
    Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology
    From Hims & Hers
    Via Business Wire
    News headline image
    Why Is Hims & Hers Stock Falling, and Should Investors Buy the Dip? ↗
    Via The Motley Fool
    News headline image
    Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’ ↗
    Via Stocktwits
    News headline image
    Hims, Block, and NRG Just Launched Huge Stock Buybacks ↗
    Via MarketBeat
    News headline image
    Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    1 Small-Cap Stock with Exciting Potential and 2 We Avoid
    Via StockStory
    MarketBeat Week in Review – 11/17 - 11/21 ↗
    Via MarketBeat
    News headline image
    2 Cash-Heavy Stocks with Competitive Advantages and 1 We Find Risky
    Via StockStory
    News headline image
    KeyCorp Delivers Sobering Outlook for LifeMD, Slashing Price Target Amidst Operational Headwinds
    Via MarketMinute

    Frequently Asked Questions

    Is Hims & Hers Health, Inc. Class A Common Stock publicly traded?
    Yes, Hims & Hers Health, Inc. Class A Common Stock is publicly traded.
    What exchange does Hims & Hers Health, Inc. Class A Common Stock trade on?
    Hims & Hers Health, Inc. Class A Common Stock trades on the New York Stock Exchange
    What is the ticker symbol for Hims & Hers Health, Inc. Class A Common Stock?
    The ticker symbol for Hims & Hers Health, Inc. Class A Common Stock is HIMS on the New York Stock Exchange
    What is the current price of Hims & Hers Health, Inc. Class A Common Stock?
    The current price of Hims & Hers Health, Inc. Class A Common Stock is 33.95
    When was Hims & Hers Health, Inc. Class A Common Stock last traded?
    The last trade of Hims & Hers Health, Inc. Class A Common Stock was at 01/08/26 02:07 PM ET
    What is the market capitalization of Hims & Hers Health, Inc. Class A Common Stock?
    The market capitalization of Hims & Hers Health, Inc. Class A Common Stock is 6.52B
    How many shares of Hims & Hers Health, Inc. Class A Common Stock are outstanding?
    Hims & Hers Health, Inc. Class A Common Stock has 7B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.